This is a webinar on SPOR and xEVMPD during which EMA’s SPOR team will cover all aspects of regulatory data management and the way SPOR and xEVMPD work.
This meeting between European Medicines Agency (EMA) and COCIR is organised in the context of the EMA annual bilateral meetings with industry stakeholder organisations.
EudraVigilance is the EU's system for managing and analysing information on adverse reactions to medicines which have been authorised or are being studied in clinical trials in the European Economic Area (EEA) and supports the reporting and analysis of suspected adverse reactions originating from clinical trials and the post-authorisation phase of...
The SPOC Working Party is responsible for monitoring and reporting events that could affect the supply of medicines in the European Union (EU).
This is webinar for SPOR and xEVMPD during which EMA’s SPOR team will cover all aspects of regulatory data management and the way SPOR and xEVMPD work today.
The Management Board is an integral governance body of the Agency. It has a supervisory role with general responsibility for budgetary and planning matters, the appointment of the Executive Director and the monitoring of the Agency's performance.
The Cancer Medicines Forum (CMF) aims to explore how EMA can contribute towards addressing remaining uncertainties about the use of cancer medicines in clinical practice.